Ads
related to: life after hodgkin's lymphoma treatment guidelines pictures women in today
Search results
Results From The WOW.Com Content Network
An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.
MOPP is a combination chemotherapy regimen used to treat Hodgkin lymphoma. The acronym is derived from the component drugs of the regimen: ustargen (also known as mechlorethamine, chlormethine, mustine, nitrogen mustard, or MSD) ncovin (also known as Vincristine or VCR) rocarbazine (also known as Matulane or Natulan)
As of 2007, ABVD is widely used as the initial chemotherapy treatment for newly diagnosed Hodgkin lymphoma. [citation needed] It has been the most effective and least toxic chemotherapy regimen available for treating early-stage Hodgkin Lymphoma. [1]
Anita Moorjani [1] is the author of five books, including the New York Times bestseller, Dying to be Me. [2]After she was diagnosed with stage 1A Hodgkin's lymphoma in 2002, and rejected conventional treatment, Moorjani was taken to a hospital in 2006 where she lay in a coma for 30 hours, during which Moorjani claims to have undergone a near-death experience.
For premium support please call: 800-290-4726 more ways to reach us
Non-Hodgkin lymphomas, which are defined as being all lymphomas except Hodgkin lymphoma, are more common than Hodgkin lymphoma. A wide variety of lymphomas are in this class, and the causes, the types of cells involved, and the prognoses vary by type. The number of cases per year of non-Hodgkin lymphoma increases with age.
Ad
related to: life after hodgkin's lymphoma treatment guidelines pictures women in today